Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Aug 21, 2025; 31(31): 110582
Published online Aug 21, 2025. doi: 10.3748/wjg.v31.i31.110582
Table 1 Comparison of baseline characteristics among the three groups, mean ± SD/n (%)
Item
Control (n = 281)
Low-dose (n = 313)
High-dose (n = 285)
Age (year)66.94 ± 8.6865.91 ± 8.7666.32 ± 9.14
Gender
Male159 (56.58)175 (55.91)170 (59.65)
Female122 (43.41)138 (44.08)115 (40.35)
BMI (kg/m2)23.65 ± 3.0323.78 ± 3.7324.82 ± 3.44
ASA grading
I8 (2.84)14 (4.47)11 (3.86)
II228 (81.14)265 (84.66)243 (85.26)
III45 (16.01)34 (10.86)31 (10.88)
Hypertension41 (14.59)32 (10.22)35 (12.28)
Diabetes14 (4.98)10 (3.19)17 (5.96)
Coronary heart disease23 (8.19)26 (8.31)20 (7.02)